FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Tuberculosis

Guidance on Surveillance of Drug Resistance in TB

08 Oct 2021

The aim of this document is to assist national tuberculosis (TB) programs in developing the strongest possible mechanisms of surveillance for drug resistance in TB, building on more than 25 years of global experience. This starts from periodic surveys of sampled patients, moving towards an ultimate goal of continuous surveillance systems based on routine drug susceptibility testing (DST). This guidance promotes certain standardized criteria for surveillance to ensure that results are comparable within and between countries over time. This document is aimed at national TB programmes and, in particular, the coordination team for surveillance ideally composed of a program manager, a laboratory specialist, a logistician, and an epidemiologist/statistician. Click here to read the report. 

PUBLISHED BY
World Health Organization
YEAR OF PUBLISHING
2021
AUTHORS
World Health Organization

Categories

For implementers
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst